AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6th day of December, 2006 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Albert C. Bristow (the “Executive”).
PHARMACEUTICAL PRODUCT SUPPLY AGREEMENT Dated January 27, 2005 By and Between DSM PHARMACEUTICALS, INC. and BARRIER THERAPEUTICS, INC.Pharmaceutical Product Supply Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • North Carolina
SALES FORCE SERVICES AGREEMENTSales Force Services Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
This Sales Force Services Agreement (this “Agreement”), with an Effective Date of March 2, 2007, sets forth the terms and conditions between Novartis Consumer Health, Inc., 200 Kimball Drive, Parsippany, N.J. 07054 (hereafter “Novartis”), and Barrier Therapeutics, Inc., 600 College Road East, Princeton, NJ 08540 (hereinafter “Barrier”).
Re: Amendment No. 1 (this “Amendment”) to the Pharmaceutical Product Supply Agreement dated January 27, 2005 (the “Agreement”) by and between DSM Pharmaceuticals, Inc. (“DSM”) and Barrier Therapeutics, Inc. (“Barrier”)Pharmaceutical Product Supply Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations
This letter confirms the recent discussions between DSM and Barrier regarding the proposed amendment of the Pharmaceutical Product Supply Agreement (the “Agreement”) referenced above. All terms and conditions defined herein are used as defined in the Agreement.
MANUFACTURING AGREEMENT DPT LABORATORIES, LTD. AND BARRIER THERAPEUTICS, INC.Manufacturing Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
This Manufacturing Agreement (the “Agreement”) is made as of this 31st day of March, 2005 by and between Barrier Therapeutics, Inc., a corporation organized under the laws of the State of Delaware, with its principal place of business at 600 College Road East, Princeton, New Jersey 08540 (hereinafter referred to as “COMPANY”) and DPT Laboratories, Ltd., a Texas Limited Partnership with a place of business at 307 East Josephine Street, San Antonio, Texas 78215 (hereinafter referred to as “DPT”).
